Principal Investigators


    Contact information of lead PI


    European Commission

    Title of project or programme

    From Patient Data to Clinical Diagnosis in Neurodegenerative Diseases

    Source of funding information

    European Commission FP7-Seventh Framework Programme

    Total sum awarded (Euro)

    € 3,148,000

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Alzheimer's disease & other dementias


    Research Abstract

    Dementia is a growing health problem with enormous costs to society: the costs currently equal 1% of the global gross-domestic product and a three-fold increase to 115 million dementia cases is expected by 2050. Addressing this grave human and economic challenge requires efficient solutions that do not exist yet: tools to detect and diagnose persons at an early phase, and interventions for delaying disease progression.

    PredictND provides an objective ICT-based approach for diagnostics of neurodegenerative diseases. It is based on the principles of evidence-based data-driven medicine and builds upon previous successful Virtual Physiological Human (VPH) projects. An existing decision support tool is enhanced to meet the needs of clinical practice and validated in real conditions across several EU regions. The first goal is to show that modern computer-based models enable earlier and more objective clinical diagnostics. The second goal is to improve cost-efficiency of early diagnostics by developing a low-cost test battery that detects persons at high risk of dementia and forwards these persons to more accurate (and expensive) clinical tests. Everything is implemented as an ICT ecosystem that integrates the clinical decision support tool with services for citizens for assessing the risk of diseases. Thus, PredictND transfers the scientific VPH concepts not only to clinical practice but to an environment suitable for solving the larger challenge of dementia.

    PredictND impacts healthcare professionals by providing tools for objective and earlier diagnostics. The tools, combined with interventions that delay disease progression will increase the quality of life for patients and their caregivers. PredictND also reduces costs to society and produces new scientific understanding of this family of diseases. Finally, PredictND combines excellent clinical, industrial and technological forces with innovative VPH technologies, providing impetus for the European industry.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: European Commission
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF